Triple

T21154203
Position Surface form Disambiguated ID Type / Status
Subject SIGA Technologies E521269 entity
Predicate hasRegulatoryApproval P24602 FINISHED
Object United Kingdom Medicines and Healthcare products Regulatory Agency — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: United Kingdom Medicines and Healthcare products Regulatory Agency | Statement: [SIGA Technologies, hasRegulatoryApproval, United Kingdom Medicines and Healthcare products Regulatory Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: United Kingdom Medicines and Healthcare products Regulatory Agency
Context triple: [SIGA Technologies, hasRegulatoryApproval, United Kingdom Medicines and Healthcare products Regulatory Agency]
  • A. UK Medicines and Healthcare products Regulatory Agency chosen
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b50d1ea481909c07e63c3ead9316 completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e7252a48788190bfdfe811fc6cfc06 completed April 21, 2026, 7:20 a.m.
Created at: April 16, 2026, 2:58 p.m.